SV

Street Verdict

Analyst Scorecard

A record of what Ganesh Dongre said publicly, with the source. Not advice.

“Recommends buying Aurobindo Pharma at ₹1220 with a stop loss at ₹1170 and a target price of ₹1300. This call is for Monday, April 28.”

Ganesh Dongre’s track record (trackable calls only): 327 graded calls · 95% CI 33–44%

Aurobindo PharmaBullishCalled 27 Apr 2025Graded 08 May 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Entry: ₹1,220, as stated.

Target ₹1,300, stop ₹1,170, as stated.

No time frame is stated, so it is tracked until a close reaches ₹1,300 or ₹1,170: there is no fixed window.

The stop ₹1,170 was reached on a close before the target ₹1,300. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹1220 on 2025-04-28 (stated entry ₹1220, LEVEL_CMP entry, filled); stop ₹1170 breached at close ₹1157.6 on 2025-05-08. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.

Tracking Aurobindo Pharma since this call

1-year tracking window
Read the original articleSee Ganesh Dongre’s full track record